pharmaceutical industry
Science
Patients Are Left With Few Options as GLP-1 Copycats Disappear
By Emily Mullin and Kate Knibbs
Business
Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs
By Kate Knibbs and Emily Mullin
Science
The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
By Kate Knibbs and Emily Mullin
The Big Story
After Shark Tank, Mark Cuban Just Wants to Break Shit—Especially the Prescription Drug Industry
By Lauren Goode
Science
It’s Shockingly Easy to Buy Off-Brand Ozempic Online, Even if You Don’t Need It
By Kate Knibbs